Progestogen-only Implants

FSRH CEU Statement on Nexplanon® Insertion Site 15 January 2020

15 January 2020

This CEU Statement provides guidance to healthcare professionals in response to a letter circulated by MSD (manufacturer of Nexplanon®) to healthcare professionals in the UK about updated guidance regarding the recommended Nexplanon® insertion site.

This document is up-to-date